Table 2.
Malignant (n = 259) | Benign (n = 67) | Healthy volunteers (n = 54) | |
---|---|---|---|
ADC (×10−3 mm2/s) (mean ± SD) | 1.02 ± 0.17 | 1.57 ± 0.26* | 1.78 ± 0.13*# |
ANCOVA | |||
ADC (×10−3 mm2/s) | 1.06 (1.04, 1.09) | 1.61 (1.55, 1.68)* | 1.83 (1.76, 1.89)*# |
Adjusted mean (95% CI)@ | |||
Malignant vs. benign | Malignant vs. healthy volunteers | Benign vs. healthy volunteers | |
Difference between means (95% CI) | 0.55 (0.55, 0.56) | 0.76 (0.76, 0.77) | 0.21 (0.21, 0.22) |
ROC analysis and ADC cutoff | |||
Malignant vs. benign | 1.23 (sensitivity 92.5%; specificity 91.1%; AUC 0.96) | ||
Malignant vs. healthy | 1.43 (sensitivity 100%; specificity 98.1%; AUC 0.99) | ||
Healthy vs. benign | 1.69 (sensitivity 75.9%; specificity 74.6%; AUC 0.79) |
@Adjusted for age.
*Denotes P < 0.05 between benign vs. malignant; malignant vs. healthy volunteers.
#Denotes P < 0.05 between benign vs. healthy volunteers.